Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Quizartinib (Vanflyta) for acute myeloid leukemia.
Journal: The Medical letter on drugs and therapeutics
Published: October 23, 2023
Therapeutic management and outcome of patients with advanced systemic mastocytosis treated with midostaurin: A comprehensive real-life study in the French national healthcare database.
Journal: Hematological oncology
Published: February 22, 2022
Systemic Mastocytosis Presenting as Pathologic Intertrochanteric Femur Fracture.
Journal: Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
Published: June 01, 2021
Correlation of NK cell RIPK1 with Prognosis of Acute Myeloid Leukemia Patients with FLT3-ITD Mutation
Journal: Zhongguo shi yan xue ye xue za zhi
Published: October 17, 2020
Improving awareness of several combination therapies for acute myeloid leukemia among oncology and hematology team members in Colorado, USA.
Journal: Hematology, transfusion and cell therapy
Published: August 30, 2020
European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis.
Journal: ESMO open
Published: October 02, 2019
Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer Center.
Journal: Leukemia research
Published: July 05, 2019
Comparison of the Kinase Profile of Midostaurin (Rydapt) with That of Its Predominant Metabolites and the Potential Relevance of Some Newly Identified Targets to Leukemia Therapy.
Journal: Biochemistry
Published: August 28, 2018
Midostaurin: A Multiple Tyrosine Kinases Inhibitor in Acute Myeloid Leukemia and Systemic Mastocytosis.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Published: August 03, 2018
Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy.
Journal: OncoTargets and therapy
Published: January 19, 2018
Last Updated: 10/31/2025